Covered recipient · General Payments record
BUSHRA AKRAM
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2021–2024
$1,098.05
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $664.76 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $159.03 | 8 |
| ABBVIE INC. | $140.10 | 6 |
| Lilly USA, LLC | $94.52 | 4 |
| GlaxoSmithKline, LLC. | $54.96 | 3 |
| Tandem Diabetes Care, Inc. | $36.50 | 1 |
| Acerta Pharma LLC | $33.97 | 2 |
| PFIZER INC. | $30.15 | 2 |
| Sandoz Inc. | $29.26 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.42 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.78 | 1 |
| Aurinia Pharma U.S., Inc. | $16.72 | 1 |
| Novo Nordisk AS | $15.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.06 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191974 | CMS |
| ABBVIE INC. | $12.12 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191976 | CMS |
| ABBVIE INC. | $34.41 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191978 | CMS |
| ABBVIE INC. | $31.67 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191980 | CMS |
| ABBVIE INC. | $11.42 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191982 | CMS |
| ABBVIE INC. | $31.42 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103191984 | CMS |
| Amgen Inc. | $27.44 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511775 | CMS |
| Amgen Inc. | $14.59 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186338 | CMS |
| Amgen Inc. | $20.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511769 | CMS |
| Amgen Inc. | $34.98 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511779 | CMS |
| Amgen Inc. | $13.85 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511777 | CMS |
| Amgen Inc. | $3.92 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186340 | CMS |
| Amgen Inc. | $23.18 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511771 | CMS |
| Amgen Inc. | $20.28 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511773 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.42 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105515741 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.55 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105728243 | CMS |
| Aurinia Pharma U.S., Inc. | $16.72 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150674932 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.78 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118255063 | CMS |
| GlaxoSmithKline, LLC. | $18.25 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116603596 | CMS |
| GlaxoSmithKline, LLC. | $17.62 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116236298 | CMS |
| GlaxoSmithKline, LLC. | $19.09 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116432693 | CMS |
| Lilly USA, LLC | $25.36 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136082774 | CMS |
| Lilly USA, LLC | $20.15 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136082258 | CMS |
| Lilly USA, LLC | $23.66 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136082868 | CMS |
| Lilly USA, LLC | $25.35 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136079279 | CMS |
| Novartis Pharmaceuticals Corporation | $27.42 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086781213 | CMS |
| Novo Nordisk Inc | $15.35 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097268394 | CMS |
| PFIZER INC. | $13.16 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131540946 | CMS |
| PFIZER INC. | $16.99 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131712119 | CMS |
| Sandoz Inc. | $29.26 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089364585 | CMS |
| Tandem Diabetes Care, Inc. | $36.50 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138741455 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.